Latest filing published 08 Feb 2021 for Intersect ENT, Inc., €25k.
Christine R. Kowalski is a declared insider of Intersect ENT, Inc., with filings sourced from SEC (Form 4). We count 6 filings; the first trade dates from 7 May 2019 and the latest from 4 February 2021.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 8 February 2021 came the latest disclosure, a share grant for €25k in Intersect ENT, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations